通过代谢调节器dPGC1控制线粒体动态,限制了Drosophila的约克诱导的瘤生长
Wei Qi Guinevere Sew1, Maria Molano-Fernández1, Zhiquan Li2
1Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
PLoS biology
|December 4, 2025
概括
代谢调节剂dPGC1抑制由瘤基因Yki.驱动的组织过度生长. 通过Yki上调调节降低dPGC1,导致具有扩大线粒体和细胞循环失调的瘤.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 代谢调节 代谢调节 代谢调节
背景情况:
- 线粒体功能障碍与癌症的发展有关.
- 河马信号通路通过YAP/Yki调节组织生长,在癌症中至关重要.
- 伊基上调驱动Drosophila影像盘中的良性组织过度生长.
研究的目的:
- 研究代谢调节器dPGC1在Yki驱动的组织过度生长中的作用.
- 阐明线粒体动力学,细胞循环调节和瘤发生之间的关系.
- 为了确定dPGC1作为潜在的瘤抑制剂.
主要方法:
- 使用Drosophila melanogaster作为一个模型生物.
- 研究了Yki上调和dPGC1枯竭对组织增生和上皮质完整性的影响.
- 分析了线粒体形态,与线粒体融合相关的基因表达,以及Cyclin E水平.
主要成果:
- dPGC1限制了Yki驱动的组织增生,并保持了上皮的完整性.
- 结合Yki上调和dPGC1耗尽导致瘤形成与扩大的线粒体.
- 瘤表现出线粒体融合基因的上调,并增加了环素E水平,促进了瘤性生长.
结论:
- dPGC1作为一个上下文依赖的瘤抑制剂.
- dPGC1协调线粒体动力学和细胞循环调节,以应对瘤基因激活.
- 这些发现为癌症发展和潜在的治疗策略提供了洞察力.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Mitochondrial Membranes
16.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K


